Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FGFR3 |
Variant | H284fs |
Impact List | frameshift |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | FGFR3 H284fs results in a change in the amino acid sequence of the Fgfr3 protein beginning at aa 284 of 806, likely resulting in premature truncation of the functional protein (UniProt.org). H284fs results in proliferation similar to wild-type Fgfr3 in a competition assay but increased transformation activity in cultured cells (PMID: 34272467), and therefore, is predicted to lead to a gain of Fgfr3 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
FGFR3 mutant FGFR3 act mut FGFR3 H284fs |
Transcript | NM_000142.5 |
gDNA | chr4:g.(1801944_1801945) |
cDNA | c.(850_849) |
Protein | p.H284fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_006713873.1 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
XM_006713870.2 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
NM_001354810.2 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
NM_001163213.2 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
XM_047449821.1 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
NM_022965.3 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
XM_006713871.2 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
NM_000142.5 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
XM_006713870.1 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
XM_011513422.1 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
XM_006713871.1 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
NM_001354809.1 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
XM_006713868.2 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
XM_006713868.1 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
NM_001354810.1 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
XM_011513422.2 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
NM_022965.4 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
XM_006713869.1 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
XM_047449824.1 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
NM_000142.4 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
XM_047449822.1 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
XM_011513420.1 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
XM_047449820.1 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
XM_047449823.1 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
XM_006713869.2 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
NM_001354809.2 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
XM_011513420.2 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
XM_006713873.2 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
NM_001163213.1 | chr4:g.(1801944_1801945) | c.(850_849) | p.H284fs | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|